REG vs VVOS · P/E 34, rev $1.55B vs rev $15.0M
Regency Centers Corporation (REG) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported REG revenue for 2025-12-31 was $1.55B. Net income was $527.5M. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
REG currently screens at market cap $12.93B and trailing P/E 33.5. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the REG and VVOS stock pages for the full models.
Not investment advice.